HASSAN S SAYEGH

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease ATLANTA, GA NPI 1194732297

General Payments — all program years on this page

$2,561.00

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,082.76 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $574.033
Food and Beverage $508.7317

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $68.064
2019 $909.678
2020 $124.484
2023 $376.0310
2024 $1,082.7620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087249041 Novartis Pharmaceuticals Corporation $31.05 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249043 Novartis Pharmaceuticals Corporation $2.24 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249047 Novartis Pharmaceuticals Corporation $0.87 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249049 Novartis Pharmaceuticals Corporation $0.87 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249051 Novartis Pharmaceuticals Corporation $31.57 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249053 Novartis Pharmaceuticals Corporation $1.94 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249055 Novartis Pharmaceuticals Corporation $0.59 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249057 Novartis Pharmaceuticals Corporation $22.13 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249059 Novartis Pharmaceuticals Corporation $0.91 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249061 Novartis Pharmaceuticals Corporation $19.84 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087249063 Novartis Pharmaceuticals Corporation $24.88 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101290210 E.R. Squibb & Sons, L.L.C. $17.84 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124893718 Abbott Laboratories $10.89 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125394359 Abbott Laboratories $504.39 03/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125394361 Abbott Laboratories $60.62 03/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125394363 Abbott Laboratories $9.02 03/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1131410491 PFIZER INC. $20.58 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138848649 Edwards Lifesciences Corporation $117.00 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138848683 Edwards Lifesciences Corporation $163.12 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148106870 Inspire Medical Systems, Inc. $42.41 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.